https://insights.citeline.com/medtech-insight/business/financing/fred-moll-backed-squaremind-raises-18m-to-bring-full-body-imaging-to-dermatologists-in-eu-us-H6G3YAG2TJCNHO62JDM5CCNPUE/2026-04-27T23:57:08.902Zalways0.5https://insights.citeline.com/resizer/avLSgY-QwfWl8y428kXbIJivDoU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/LLOSHKY23VBWZNAFALH7WACGMA.jpeghttps://insights.citeline.com/pink-sheet/biosimilars-and-generics/generics/top-court-ruling-widens-competition-path-for-generic-peptides-in-europe-6DMOFUZHABDBRIL6X66UKC6JUU/2026-04-27T21:59:02.568Zalways0.5https://insights.citeline.com/resizer/oVVJVpG41HfbT6Mu-xgYZviRVgM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HWGKHOWNEZHWLAYYSDNNC6BKA4.jpghttps://insights.citeline.com/pink-sheet/r-and-d/clinical-trials/sponsors-must-take-proactive-role-on-safety-under-new-uk-clinical-trials-rules-LIGSYJKPZ5CZLMZYQ46OA4MMVU/2026-04-27T21:58:34.943Zalways0.5https://insights.citeline.com/resizer/TkaWuECR6t19Dte7gynw-QPD1YU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/5GN4HHWRPVAT5BYTENW5DPNSUI.jpghttps://insights.citeline.com/pink-sheet/advanced-technologies/cell-and-gene-therapies/car-t-follow-up-period-could-be-reduced-to-five-years-stakeholders-argue-MQB7GORPINDXDBRRM44B3DQISQ/2026-04-27T21:58:21.295Zalways0.5https://insights.citeline.com/resizer/4_3LvaOMG6XrymLTeMU-Mnw9u2g=/cloudfront-us-east-1.images.arcpublishing.com/norstella/AZCISM5XWNH5JKMMMM4OBKKTMY.jpghttps://insights.citeline.com/pink-sheet/market-access/german-bill-could-extend-generic-drug-price-controls-to-pd-l1-inhibitors-and-others-O64TWJPCENEXLFYQFVHXUGMN6E/2026-04-27T21:57:55.814Zalways0.5https://insights.citeline.com/resizer/qqPjqWnODkEGDBCbB_UnKCPMCQY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/57YBLP2QTJDERCHJOZNSSWC5JE.jpghttps://insights.citeline.com/pink-sheet/r-and-d/clinical-trials/risk-based-era-begins-for-uk-clinical-trials-as-landmark-regulations-set-to-take-effect-AZFI5QTLIRFLJLYLL36I7RD77A/2026-04-27T21:57:28.835Zalways0.5https://insights.citeline.com/resizer/Cx316PxQNS1ET-uWvPN2IeGDUkY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ZBC47V7Z7ZEO5EPHEGWTCW5MSA.jpghttps://insights.citeline.com/pink-sheet/pathways-and-standards/user-fees/gdufa-iv-talks-reach-tentative-agreement-america-first-application-fee-waiver-added-6XEXQBJHDRHALOI3G3DL5BPGMY/2026-04-27T21:57:11.028Zalways0.5https://insights.citeline.com/resizer/q2DP6SqWe5SEdhZy-K0jW-uI7FU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/5KL7IOS5TFFSHNDICC6VFJGCFM.jpghttps://insights.citeline.com/pink-sheet/market-access/medicare-medicaid-patients-could-face-higher-costs-from-rx-to-otc-switches-F4MOM7T7JVAFVNEUVEWZ4NTCFA/2026-04-27T21:57:00.244Zalways0.5https://insights.citeline.com/resizer/8_gTx-KQ7-kJhAicjZM-Z_bVPKo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/AZA4BBWJI5ECROKGRAE2P36QNA.jpghttps://insights.citeline.com/medtech-insight/digital-technologies/ai/ama-says-congress-must-act-to-ensure-safety-of-ai-chatbots-dispensing-mental-health-advice-R4Q2WA7XLRBARIV3V4PA7HTBAU/2026-04-27T21:17:47.925Zalways0.5https://insights.citeline.com/resizer/WrZ0W0fhTUkPWpT2mIqe5P-hwIc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SGHRYP7NRBCQNOXUBG3OIABBYI.jpghttps://insights.citeline.com/medtech-insight/digital-technologies/cybersecurity/months-after-stryker-cybersecurity-attack-medtronic-hit-as-healthcare-threats-reach-record-high-K3OAETD6J5A4LE3XFA3J3X53A4/2026-04-27T19:11:02.703Zalways0.5https://insights.citeline.com/resizer/xVakX7KqFBHgOhqfJae2YyYp9zA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QRMYEARESZCALDPBZ3GHT747QE.jpghttps://insights.citeline.com/hbw-insight/beauty/policy-and-regulation/legal/sephora-will-safeguard-against-anti-aging-tween-marketing-in-agreement-with-connecticut-HED37KZVRRBWTLZB6TEMN7IMUQ/2026-04-27T19:09:46.237Zalways0.5https://insights.citeline.com/resizer/qGY_VQw4kF6s7QdZrDfdxP2p8Sk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/R5UIEZWK6ZICVB25YGECB265PY.jpghttps://insights.citeline.com/pink-sheet/biosimilars-and-generics/generics/gdufa-iv-industry-could-lower-application-fees-by-raising-program-fees-6IXCSAUL2FHWBCMF5QYXXNEBGU/2026-04-27T18:05:48.186Zalways0.5https://insights.citeline.com/resizer/Gv_OElJaTVPupnOv-IzYBA0yC3w=/cloudfront-us-east-1.images.arcpublishing.com/norstella/2X3OLDEYHJE3FGMNQVBWDE6NF4.jpghttps://insights.citeline.com/scrip/therapeutic-category/immunological/fcrn-inhibitors-a-promising-pipeline-in-a-product-frontier-32GTAILE5RGBFPYRLSQEQA3OO4/2026-04-27T16:11:30.428Zalways0.5https://insights.citeline.com/resizer/apmg2YNC689adHZtSeUcOBjBV18=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GLW7VQMM3ZFCNLL2KJ3YS33Y3M.jpghttps://insights.citeline.com/hbw-insight/wellness/business/earnings/premium-supplements-grow-but-nutrition-sales-down-for-nestle-UMHH765JQBCNROZSTGOCNENI6I/2026-04-27T15:48:15.485Zalways0.5https://insights.citeline.com/resizer/NyvR89J6tEoPetqRamRATkHNNko=/cloudfront-us-east-1.images.arcpublishing.com/norstella/F7AQ2GH345NRDHWXYKV5SKDOJM.jpghttps://insights.citeline.com/generics-bulletin/business/strategy/hikma-abandons-503b-compounding-and-strikes-fresh-inhalers-deal-ONUJSLJWUFFALHVFVASGAUSXLA/2026-04-27T14:19:52.365Zalways0.5https://insights.citeline.com/resizer/fJO1_Y6WIY350riKafOsFFjVBM8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/KHTGDIPP3JCPRGYNFCPFJFQHPE.jpghttps://insights.citeline.com/scrip/therapeutic-category/immunological/why-viridian-wants-in-on-fcrns-despite-being-late-to-the-game-V6EVRZKGBJCCHGBCIUBCPR2N3A/2026-04-27T12:22:48.532Zalways0.5https://insights.citeline.com/resizer/uXXGs90ONFywxfn0AbFuds6PlU4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/26JMYZ5IJVFYVPZV75AREJ6Q2A.jpghttps://insights.citeline.com/in-vivo/innovation/advanced-therapies/editing-heart-disease-out-of-our-dna-5GOEW27TDBC5NPMSKYIK4VGNIA/2026-04-27T12:03:56.677Zalways0.5https://insights.citeline.com/resizer/JmgCxLoAFoidgW_s_gvFPWfl9A4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/WMOWKU4ATBEK3CEZW4JNUEC2VQ.jpghttps://insights.citeline.com/generics-bulletin/business/earnings/formycon-sets-out-growth-strategy-after-missing-fy2025-financial-guidance-MBB2I4DXERC2LMPE2VAFIKO4WM/2026-04-27T11:46:21.228Zalways0.5https://insights.citeline.com/resizer/pzOKAoZ-UobmhYZO4mGzcObM97c=/cloudfront-us-east-1.images.arcpublishing.com/norstella/MRF4O55JM5E4NJQBOPMW7PBFCM.jpghttps://insights.citeline.com/generics-bulletin/business/deals/sun-speeds-into-biosimilars-with-1175bn-organon-platform-7RKYUNYRG5EOJJTHI7L7LYPIKA/2026-04-27T11:03:42.715Zalways0.5https://insights.citeline.com/resizer/239GPcdSNSWi9iWA_8a-dCilVMQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/PDLEBZYI3NO4BNNHWDAOZJNCQU.jpghttps://insights.citeline.com/scrip/business/start-ups-and-smes/hard-hit-uk-biotech-lifted-by-ma-and-financing-in-q1-Q3Z25JYZ5JC37JWPE6HUVJ3PHU/2026-04-27T08:52:57.885Zalways0.5https://insights.citeline.com/resizer/DrPbLpJJJcakgYlu0a18b_UK8cY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/YXDAZTBX75JQFIECRJHHY74WJI.jpghttps://insights.citeline.com/pink-sheet/product-reviews/us-advisory-committees/recent-and-upcoming-us-fda-advisory-committee-meetings-YLA6SZESNVCVNE26KRPTWJ5FVA/2026-04-27T08:42:35.857Zalways0.5https://insights.citeline.com/resizer/zK-1qhNmlz4zZcY6O0wKSeyretY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/RGEVRT2KERADXPSY5GK6MDEY7M.jpghttps://insights.citeline.com/pink-sheet/pathways-and-standards/approval-standards/us-fda-urged-to-modernize-evidence-standards-for-rx-to-otc-switches-MMZ64MZE3BF6RPVALFDUXVD66A/2026-04-27T08:41:45.593Zalways0.5https://insights.citeline.com/resizer/NdmuROJbGEKuWVuGgUNsPYdutCk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3FXHXEKPPBGYFJVK5FKF2UOBIY.jpghttps://insights.citeline.com/pink-sheet/product-reviews/eu-chmp/ema-clears-path-for-novartis-to-expand-market-for-sma-gene-therapy-itvisma-LMPNF6QTHZFFVCJZ665YDXPLEM/2026-04-27T08:41:06.586Zalways0.5https://insights.citeline.com/resizer/HMBCjbtQ_f3uqGiLc5dDLYhRoZE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/5KQNPH3YFZAMJCO6W7NWZZ6OAQ.jpghttps://insights.citeline.com/scrip/focus-on-asia/india/sun-makes-bold-bet-with-1175bn-organon-deal-BBMJC3F55ZC3TIV2RSS5QZDOOI/2026-04-27T08:40:37.719Zalways0.5https://insights.citeline.com/resizer/5-RMVDCbwNiU1zYDXozPRR3FVLE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/B4V2YNYG45CU5IZCKHEJZOROII.jpghttps://insights.citeline.com/pink-sheet/product-reviews/eu-chmp/sanofis-tolebrutinib-gets-ema-backing-after-failing-to-win-over-us-regulators-BRGAODLQGVE7HPTOYSUCDBVWBM/2026-04-27T08:40:16.644Zalways0.5https://insights.citeline.com/resizer/HYYCc6maZg9sdOC2Q0J303oqdDw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/J7J426LVQBHJLEU4SRDXL37UP4.jpghttps://insights.citeline.com/pink-sheet/pathways-and-standards/approval-standards/precision-psychiatry-targeted-therapy-is-enormous-opportunity-us-fda-official-says-EY3WPEJO5REPBHUKSCWEWRQBFI/2026-04-27T08:38:31.442Zalways0.5https://insights.citeline.com/resizer/0GTdRHR0knl3Q1e1rM4XcBlesao=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IPTW7PZUQJM5VBG53OG7ELRWGQ.jpghttps://insights.citeline.com/pink-sheet/product-reviews/eu-chmp/arrowheads-redemplo-nears-eu-approval-as-first-sirna-therapy-for-rare-lipid-disorder-F4VZWLISQVACJEJ4I5ZAEXUMN4/2026-04-27T08:37:26.176Zalways0.5https://insights.citeline.com/resizer/jMEms-mFlDkPkTC9DwO-1LaMmE4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/PHEF5HMBQRAI3HFXQYHUABIO6M.jpghttps://insights.citeline.com/pink-sheet/pathways-and-standards/approval-standards/rfk-jr-hearings-preview-of-congressional-oversight-focus-after-mid-term-elections-ZFCXERBLV5CNDPCBXK54EKJ5J4/2026-04-27T08:34:59.528Zalways0.5https://insights.citeline.com/resizer/zVM5evohqLNbho_JxMGteTtPfys=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3LH372A7F5FTRJ7NQMM55QLOHQ.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/recalls/fda-issues-early-alert-on-medline-syringes-WN4P2IXNH5ABFMZKTNF4N4VN5U/2026-04-27T08:08:15.642Zalways0.5https://insights.citeline.com/resizer/9MTkME7oMYrMXtAnWxR8l0j4CTo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/FNF4S7MRJFFF7LCJJBOJASJ7IE.jpghttps://insights.citeline.com/in-vivo/business-strategy/leaders-are-paying-for-the-wrong-skills-report-finds-5AOVSMC3UFD4VIHOHAKCYJRU5I/2026-04-27T07:41:15.223Zalways0.5https://insights.citeline.com/resizer/ttV3jl10srfaBCdLs3hFgQn8aAU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SYJHANYDKBGUFD6QC3BU5VSISQ.jpghttps://insights.citeline.com/scrip/r-and-d/clinical-trials/ql-biopharm-unveils-oral-once-weekly-glp-1-peptide-OYIOSZFMAZBJHPC2HM5J6455LI/2026-04-27T06:12:08.338Zalways0.5https://insights.citeline.com/resizer/ZBr2NkrB002jNMoeWEeHGcEyVFU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ZBHG3VRJQVHBNOPUWNOZG6LGQE.jpghttps://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-DBDTTSHFXNBTVLT6PE4MX45B74/2026-04-27T02:15:38.548Zalways0.5https://insights.citeline.com/resizer/yYwvRVmhblLIMA0HOvUK6LfqRwQ=/cloudfront-us-east-1.images.arcpublishing.com/norstella/G7XLNG5DWRIZTCTW357HEKFDOE.jpghttps://insights.citeline.com/companies/iclpharma/2026-04-27T00:05:50.157Zalways0.5https://insights.citeline.com/companies/tm3-therapeutics/2026-04-27T00:05:39.991Zalways0.5https://insights.citeline.com/companies/johnpro-biotech/2026-04-27T00:05:29.854Zalways0.5https://insights.citeline.com/companies/himedia-laboratories-private-limited/2026-04-27T00:05:21.91Zalways0.5https://insights.citeline.com/companies/innothera/2026-04-27T00:05:15.998Zalways0.5https://insights.citeline.com/companies/terranova-therapeutics/2026-04-27T00:05:09.803Zalways0.5https://insights.citeline.com/companies/ginkgopharma-co-ltd/2026-04-27T00:05:03.934Zalways0.5https://insights.citeline.com/companies/laboratoire-ccd2026-04-27T00:04:58.076Zalways0.5https://insights.citeline.com/companies/hankook-korus-pharm2026-04-27T00:04:51.781Zalways0.5https://insights.citeline.com/companies/origenix-technologies/2026-04-27T00:04:45.903Zalways0.5https://insights.citeline.com/companies/integrant-pty-ltd/2026-04-27T00:04:39.874Zalways0.5https://insights.citeline.com/companies/himuka-am-pharma2026-04-27T00:04:33.788Zalways0.5https://insights.citeline.com/companies/oryx-pharmaceuticals2026-04-27T00:04:27.968Zalways0.5https://insights.citeline.com/companies/jilin-jian-yisheng-pharmaceutical-co-ltd2026-04-27T00:04:21.815Zalways0.5https://insights.citeline.com/companies/hangzhou-zhongmei-huadong-pharmaceutical-co-ltd2026-04-27T00:04:15.735Zalways0.5https://insights.citeline.com/companies/visum-pharmaceutical-co-ltd/2026-04-27T00:04:09.76Zalways0.5https://insights.citeline.com/companies/kubota-vision-inc2026-04-27T00:04:03.711Zalways0.5https://insights.citeline.com/companies/jubilant-therapeutics-inc2026-04-27T00:03:57.656Zalways0.5https://insights.citeline.com/companies/help-pharmaceuticals-sa2026-04-27T00:03:51.585Zalways0.5https://insights.citeline.com/companies/tiumbio-co-ltd2026-04-27T00:03:45.522Zalways0.5https://insights.citeline.com/companies/kemia-inc2026-04-27T00:03:39.662Zalways0.5https://insights.citeline.com/companies/glac-biotech-co-ltd2026-04-27T00:03:33.468Zalways0.5https://insights.citeline.com/companies/indanio-bioscience-inc2026-04-27T00:03:27.657Zalways0.5https://insights.citeline.com/companies/iberhospitex-sa2026-04-27T00:03:21.367Zalways0.5https://insights.citeline.com/companies/scintipharma-inc2026-04-27T00:03:15.342Zalways0.5https://insights.citeline.com/companies/the-or-company2026-04-27T00:03:09.326Zalways0.5https://insights.citeline.com/companies/genoway-sa2026-04-27T00:03:03.343Zalways0.5https://insights.citeline.com/companies/humana-inc2026-04-27T00:02:57.22Zalways0.5https://insights.citeline.com/companies/taewoong-medical-co-ltd2026-04-27T00:02:45.274Zalways0.5https://insights.citeline.com/companies/st-georges-university-of-london2026-04-27T00:02:39.123Zalways0.5https://insights.citeline.com/companies/kvk-tech-inc2026-04-27T00:02:33.103Zalways0.5https://insights.citeline.com/companies/strand-life-sciences2026-04-27T00:02:27.163Zalways0.5https://insights.citeline.com/companies/trion-pharma-gmbh/2026-04-27T00:02:20.976Zalways0.5https://insights.citeline.com/companies/infomedics-inc2026-04-27T00:02:14.983Zalways0.5https://insights.citeline.com/companies/iso-tex-diagnostics-inc2026-04-27T00:02:09.029Zalways0.5https://insights.citeline.com/companies/henlix-biotech-co-ltd2026-04-27T00:02:03.08Zalways0.5https://insights.citeline.com/companies/gnsbio2026-04-27T00:01:57.048Zalways0.5https://insights.citeline.com/companies/immunobiology-ltd2026-04-27T00:01:48.015Zalways0.5https://insights.citeline.com/companies/jsw-lifesciences-gmbh2026-04-27T00:01:36.094Zalways0.5https://insights.citeline.com/companies/g-pohl-boskamp-gmbh-co2026-04-27T00:01:24.15Zalways0.5https://insights.citeline.com/companies/topotarget-as2026-04-27T00:01:11.814Zalways0.5https://insights.citeline.com/companies/dompe-farmaceutici-spa2026-04-27T00:01:00.931Zalways0.5